Doxycycline for rosacea

Efracea (doxycycline) is a new oral treatment for facial rosacea in patients aged 12 years and over. The recommended dose of the product is one 40mg modified-release capsule once daily.

View Efracea drug record

Further information: Galderma

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more